Biofrontera Share Price

Biofrontera Share Price

NASDAQ: BFRI | Micro Cap | Healthcare
$0.57
-$0.03 (-4.93%) Last updated on 20 Nov, 2026 | 02:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Biofrontera Stock Performance

Open
$0.60
Prev. Close
$0.60
Circuit Range
N/A
Day Range
$0.57 - $0.60
Year Range
$0.57 - $1.66
Volume
1,145
Average Traded
$0.58

Biofrontera Share Price Today

As of 20 November 2026, Biofrontera Inc.'s share price is $0.57. The stock opened at $0.60, compared to its previous close of $0.60. During today's trading session, Biofrontera Inc.'s share price traded between $0.57 and $0.60, with an average price of $0.58. Over the past 52 weeks, the stock has recorded a high of $1.66 and a low of $0.57. In terms of performance, Biofrontera Inc.'s share price has declined by 31.30% over the last six months and is down 28.73% on a year-on-year basis.

Biofrontera Share Price Chart

Line chart of the Biofrontera price trend over the selected period. The price fell overall, ranging from 0.60 to 0.61, ending at 0.60.
$0.57$0.60
L
Show Current Price
H

Biofrontera Stock Fundamentals & Key Indicators

Market Cap
$5.80M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.34
Revenue (TTM)
$41.71B
Return On Equity (TTM)
2526.34%
Profit Margin
-25.27%
Debt to Equity
-19.54
Quarterly Earnings Growth YoY
-213.83%

Biofrontera Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$17.10$10.08$12.00$9.07
Net Profit$5.64-$4.75-$0.60-$6.42
Net Profit Margin32.98%-47.12%-5.00%-70.78%
Income ChangeN/A-184.22%87.37%-970.00%

Biofrontera Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$28.67$34.07$37.32$41.71
Net Profit-$0.64-$20.13-$17.76-$10.54
Net Profit Margin-2.23%-59.08%-47.59%-25.27%
Income ChangeN/A-3045.31%11.77%40.65%

Biofrontera Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets10.481.44.867.74
Current Assets18.0820.723.0843.14
Total Assets28.5622.127.9350.88
Non Current Liabilities6.195.655.056.11
Current Liabilities11.912.0218.0920.89
Total Liabilities18.0817.6723.1427.01
Shareholders' Equity10.484.434.7923.88

Biofrontera Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-13.36-10.27-24.9-16.2
Investing3.00.00.62-5.16
Financing10.8514.848.4114.02

Corporate Actions

Split
Ex-date: 05 Jul 2023

About Biofrontera

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

Biofrontera Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.85
$0.57
-33.33%
Oct 2026
$1.03
$0.85
-21.56%
Sep 2026
$1.51
$1.09
-27.09%
Aug 2026
$1.17
$1.50
+28.33%
Jul 2026
$1.01
$1.17
+22.50%
Jun 2026
$0.88
$0.95
+14.58%
May 2026
$1.07
$0.83
-23.50%
Apr 2026
$0.81
$1.08
+35.62%
Mar 2026
$0.89
$0.80
-12.28%
Feb 2026
$0.89
$0.91
-1.94%
Jan 2026
$0.59
$0.93
+55.00%
Dec 2025
$0.83
$0.60
-25.00%

Biofrontera Share Price FAQs